Researcher Profiles

Return to member profile

Kathleen W. Scotto, PhD

Publications since 2011

Munoz, J. L. Rodriguez-Cruz, V. Greco, S. J. Nagula, V. Scotto, K. W. Rameshwar, P. Temozolomide induces the production of epidermal growth factor to regulate MDR1 expression in glioblastoma cells. Mol Cancer Ther, In process, . (PMID: 25053824)

Xie, X. Bansal, N. Shaik, T. Kerrigan, J. E. Minko, T. Garbuzenko, O. Abali, E. E. Johnson-Farley, N. Banerjee, D. Scotto, K. W. Bertino, J. R. A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts. Oncotarget, 5:901-907, . (PMID: 24658650, PMCID: PMC4011592)

Xie, X. Kerrigan, J. E. Minko, T. Garbuzenko, O. Lee, K. C. Scarborough, A. Abali, E. E. Budak-Alpdogan, T. Johnson-Farley, N. Banerjee, D. Scotto, K. W. Bertino, J. R. Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer. Cancer Biol Ther, 14:742-751, . (PMID: 23792570)

Hsieh, Y. C. Tedeschi, P. Adebisi Lawal, R. Banerjee, D. Scotto, K. Kerrigan, J. E. Lee, K. C. Johnson-Farley, N. Bertino, J. R. Abali, E. E. Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs. Mol Pharmacol, 83:339-353, . (PMID: 23197646, PMCID: PMC3558814)

Roussel, B. Johnson-Farley, N. Kerrigan, J. E. Scotto, K. W. Banerjee, D. Felczak, K. Pankiewicz, K. W. Gounder, M. Lin, H. Abali, E. E. Bertino, J. R. A second target of benzamide riboside: Dihydrofolate reductase. Cancer Biol Ther, 13:1290-1298, . (PMID: 22954684, PMCID: PMC3493437)

Miletti-Gonzalez, K. E. Murphy, K. Kumaran, M. N. Ravindranath, A. K. Wernyj, R. P. Kaur, S. Miles, G. D. Lim, E. Chan, R. Chekmareva, M. Heller, D. S. Foran, D. Chen, W. Reiss, M. Bandera, E. V. Scotto, K. Rodriguez-Rodriguez, L. Identification of function for CD44 intracytoplasmic domain (CD44-ICD): modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response element. J Biol Chem, 287:18995-19007, . (PMID: 22433859, PMCID: PMC3365933)

Ding, R. Shi, J. Pabon, K. Scotto, K. W. Xanthines down-regulate the drug transporter ABCG2 and reverse multidrug resistance. Mol Pharmacol, 81:328-337, . (PMID: 22113078, PMCID: PMC3286305)